Fundraising FoxArsenal Bridge Venture — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Morphimmunemorphimmune.cominMay 2023SEC filingmedium confidence
HealthtechWest Lafayette, US
Philip Low, Ph.D.(Director)Sunil Singhal, M.D.(Director)Isaac Barchas(Director)Clay B. Siegall, Ph.D.(Executive Officer, Director)Ronald Martell(Director)inFranklyn Prendergast, M.D., Ph.D.(Director)
Board seatIsaac Barchas· per SEC Form D · $15M raise · filed May 2023
Co-investorsEcoR1 CapitalJanus Henderson InvestorsREDMILE
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.